Fulcrum Therapeutics, Inc.
FULC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001680581
In the last 90 days, Fulcrum Therapeutics, Inc. insiders filed 2 open-market purchases and 0 sales; 154 institutions reported holding it in 13F filings for Q2 2026, worth $291.3M in total; no superinvestor holds it.
13F holders, Q2 2024
Institutional positions in Fulcrum Therapeutics, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 121
- −5 vs. Q1 2024
- Shares held
- 64.8M
- +4.43M (+7.3%) vs. Q1 2024
- Total value
- $402.0M
- −$167.7M (−29.4%) vs. Q1 2024
- New holders
- 31
- 46 more added
- Sold out
- 36
- 25 more reduced
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting FULC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 154 | $291.3M |
| Q1 2026 | 169 | $550.1M |
| Q4 2025 | 172 | $762.7M |
| Q3 2025 | 129 | $494.9M |
| Q2 2025 | 122 | $374.5M |
| Q1 2025 | 117 | $147.8M |
| Q4 2024 | 119 | $243.4M |
| Q3 2024 | 130 | $196.4M |
| Q2 2024 | 121 | $402.0M |
| Q1 2024 | 126 | $569.7M |
| Q4 2023 | 101 | $412.3M |
| Q3 2023 | 81 | $250.4M |
| Q2 2023 | 88 | $183.2M |
| Q1 2023 | 116 | $172.2M |
| Q4 2022 | 110 | $368.5M |
| Q3 2022 | 105 | $422.1M |
| Q2 2022 | 102 | $196.6M |
| Q1 2022 | 108 | $929.9M |
| Q4 2021 | 110 | $657.3M |
| Q3 2021 | 101 | $1.03B |
| Q2 2021 | 67 | $280.8M |
| Q1 2021 | 68 | $317.0M |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Fulcrum Therapeutics, Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Simplify Asset Management Inc. | 674,832 | $4.18M | 0.37% | −1,199−0.2% | Reduced |
| StemPoint Capital LP | 696,464 | $4.32M | 1.27% | +289,356+71.1% | Added |
| Rock Springs Capital Management LP | 727,673 | $4.51M | 0.14% | 00.0% | Unchanged |
| Propel Bio Management, LLC | 750,000 | $4.65M | 3.02% | 00.0% | Unchanged |
| Deutsche Bank AG | 849,193 | $5.26M | 0.00% | +26,095+3.2% | Added |
| State Street Corp | 1,041,274 | $6.46M | 0.00% | +784,413+305.4% | Added |
| Vestal Point Capital, LP | 1,160,000 | $7.19M | 0.54% | +465,000+66.9% | Added |
| Morgan Stanley | 1,234,813 | $7.66M | 0.00% | +77,676+6.7% | Added |
| Geode Capital Management, LLC | 1,307,377 | $8.11M | 0.00% | +743,919+132.0% | Added |
| Jefferies Financial Group Inc. | 1,433,316 | $8.89M | 0.17% | +281,590+24.4% | Added |
| MPM Oncology Impact Management LP | 1,444,851 | $8.96M | 1.39% | +307,743+27.1% | Added |
| Dimensional Fund Advisors LP | 1,480,926 | $9.18M | 0.00% | +176,114+13.5% | Added |
| Citadel Advisors LLC | 1,777,112 | $11.0M | 0.01% | +451,733+34.1% | Added |
| TRV GP IV, LLC | 2,343,154 | $14.5M | 7.18% | 00.0% | Unchanged |
| Suvretta Capital Management, LLC | 2,541,046 | $15.8M | 0.64% | −307,440−10.8% | Reduced |
| Cowen and Company, LLC | 2,964,127 | $18.4M | 0.51% | −749,807−20.2% | Reduced |
| Vanguard Group Inc | 3,071,143 | $19.0M | 0.00% | +532,478+21.0% | Added |
| BlackRock Inc. | 4,798,522 | $29.8M | 0.00% | +3,257,313+211.3% | Added |
| FMR LLC | 5,329,946 | $33.0M | 0.00% | −34,719−0.6% | Reduced |
| RTW Investments, LP | 5,845,956 | $36.2M | 0.56% | 00.0% | Unchanged |
| Ra Capital Management, L.P. | 11,609,704 | $72.0M | 0.95% | 00.0% | Unchanged |
| Affinity Asset Advisors, LLC | 0 | $0 | 0.00% | −550,339−100.0% | Sold out |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −223,400−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −171,507−100.0% | Sold out |
| CIBC World Markets Corp | 0 | $0 | 0.00% | −150,000−100.0% | Sold out |
| HSBC Holdings PLC | 0 | $0 | 0.00% | −149,627−100.0% | Sold out |
| Laurion Capital Management LP | 0 | $0 | 0.00% | −144,721−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −123,408−100.0% | Sold out |
| Man Group plc | 0 | $0 | 0.00% | −102,226−100.0% | Sold out |
| Point72 Asia (Singapore) Pte. Ltd. | 0 | $0 | 0.00% | −89,547−100.0% | Sold out |
| Bridgeway Capital Management, LLC | 0 | $0 | 0.00% | −88,564−100.0% | Sold out |
| Brevan Howard Capital Management LP | 0 | $0 | 0.00% | −88,483−100.0% | Sold out |
| Gilder Gagnon Howe & Co LLC | 0 | $0 | 0.00% | −65,600−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −54,416−100.0% | Sold out |
| PDT Partners, LLC | 0 | $0 | 0.00% | −49,518−100.0% | Sold out |
| Centiva Capital, LP | 0 | $0 | 0.00% | −43,080−100.0% | Sold out |
| Acuitas Investments, LLC | 0 | $0 | 0.00% | −33,224−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −29,169−100.0% | Sold out |
| Denali Advisors LLC | 0 | $0 | 0.00% | −27,100−100.0% | Sold out |
| Brown Wealth Management, LLC | 0 | $0 | 0.00% | −25,000−100.0% | Sold out |
| Wolverine Trading, LLC | 0 | $0 | 0.00% | −23,579−100.0% | Sold out |
| Jacobs Levy Equity Management, Inc | 0 | $0 | 0.00% | −20,472−100.0% | Sold out |
| Blackstone Group Inc. | 0 | $0 | 0.00% | −19,216−100.0% | Sold out |
| Polymer Capital Management (HK) LTD | 0 | $0 | 0.00% | −18,874−100.0% | Sold out |
| LMR Partners LLP | 0 | $0 | 0.00% | −17,539−100.0% | Sold out |
| Principal Financial Group Inc | 0 | $0 | 0.00% | −16,233−100.0% | Sold out |
| CTC Alternative Strategies, Ltd. | 0 | $0 | 0.00% | −14,700−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −13,154−100.0% | Sold out |
| Atom Investors LP | 0 | $0 | 0.00% | −12,658−100.0% | Sold out |
| Capstone Investment Advisors, LLC | 0 | $0 | 0.00% | −10,900−100.0% | Sold out |
| Omers Administration Corp | 0 | $0 | 0.00% | −10,600−100.0% | Sold out |
| Fernwood Investment Management, LLC | 0 | $0 | 0.00% | −7,613−100.0% | Sold out |
| Marquette Asset Management, LLC | 0 | $0 | 0.00% | −6,039−100.0% | Sold out |
| Catalyst Funds Management Pty Ltd | 0 | $0 | 0.00% | −2,594−100.0% | Sold out |
| Quadrant Capital Group LLC | 0 | $0 | 0.00% | −1,038−100.0% | Sold out |
| GAMMA Investing LLC | 0 | $0 | 0.00% | −45−100.0% | Sold out |
| Macquarie Group Ltd | 0 | $0 | 0.00% | −4,365−100.0% | Sold out |